Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 178 member B (FAM178B) is a protein-coding gene in humans, most highly expressed in skeletal muscle and various regions of the brain[1][4][5]. The protein is primarily composed of alpha-helices and may adopt a coiled-coil tertiary structure[1]. While its precise biological function remains unclear, strong expression in the central nervous system and associations with diseases like glioma and autism spectrum disorder suggest potential roles in neuronal physiology and disease susceptibility[2][3]. FAM178B has several transcript isoforms, and its high evolutionary conservation across vertebrates and invertebrates points to a functionally significant, though as yet undefined, biological role[1]. It is not catalogued as a canonical therapeutic target (receptor/enzyme/transporter), nor is it the focus of current drug development or clinical biomarker use[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 178 member B (FAM178B).